OpenAI CEO Sam Altman and Meta both announced $1 million donations, and Amazon and Apple CEO Tim Cook have also reportedly ...

The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s ...

Hims & Hers Health (NYSE:HIMS – Free Report) had its target price lifted by Piper Sandler from $21.00 to $24.00 in a report ...

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.

Analyst Ryan MacDonald of Needham maintained a Buy rating on Hims & Hers Health (HIMS – Research Report), boosting the price target to ...

Ratings for Hims & Hers Health HIMS were provided by 12 analysts in the past three months, showcasing a mix of bullish and ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $26.63 which represents a slight increase of $1.43 or 5.67% from the prior close of $25.2. The stock opened at $25.11 and ...

BTIG initiated coverage of Hims & Hers with a Buy rating and $35 price target The firm says its likes Hims & Hers because of its ...

Hims & Hers' robust Q3 2024 performance, driven by a 44% increase in subscribers and 77% y/y revenue growth, underscores its ...

根据最近的SEC文件显示，Hims & Hers Health, Inc. (NYSE:HIMS)的首席法务官Boughton Soleil于2025年1月6日执行了一系列股票交易。Soleil总共出售了268,932股A类普通股，每股价格在27.72美元至28.00美元之间。出售的股票总价值约为746万美元。

在医疗保健行业的发展趋势中，远程医疗正逐渐成为未来的热门领域。2025年1月7日，华尔街研究机构BTIG对远程医疗公司Hims & Hers Health首次发布了“买入”评级，并设定了35美元的目标价。BTIG表示，该公司凭借科技和便捷性正在重新定义医疗保健行业，吸引了众多投资者的关注。这一评级的发布，可能会对市场产生重要影响，值得投资者深入分析。

BTIG预计Hims & Hers将继续经历强劲的收入增长，特别是在GLP-1和肥胖健康产品类别。该公司的积极立场进一步得到了对公司管理层的信心和整体增长前景的支持。 BTIG设定的新$35.00目标价反映了该公司对Hims & Hers未来盈利能力的预期，因为公司继续扩大其在健康服务市场的影响力和覆盖范围。